PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • February 2017 •
  • 196 pages •
  • Report ID: 4794294
PharmaFocus: Tauopathies - Global Market Analysis

Summary

Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no treatments approved in this therapy area and five tauopathies are attracting increasing attention from pharmaceutical companies in particular. These are: progressive Supranuclear palsy (PSP), CorticoBasal Degeneration (CBD), frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), Pick’s disease (clinically referred to as bvFTD), and chronic traumatic encephalopathy (CTE). In these indications, symptoms often present as behavioral (e.g. disinhibition, apathy), cognitive (e.g. memory loss), language (e.g. slurring of speech), or motor (e.g. falls, tremor) deficits.

According to Akiko Fukui, Healthcare Analyst, there are currently no approved therapies to treat tauopathy patients, and as such, the first-to-market drug will secure a high patient share, boosting sales and establishing a strong company presence in the tauopathies space. In turn, the market will be made more attractive for other manufacturers, as strong sales performance of the first product will reduce financial risk. Moreover, the possibility of expanding sales from the tauopathies market into the much larger Alzheimer’s disease space is another strong incentive for drug manufacturers, as successful entry into these markets would provide huge revenue.

The report “PharmaFocus: Tauopathies - Global Market Analysis” states that once the first drug in the tauopathies market is approved, it could incentivize R&D from other pharma companies, setting an example for an effective therapeutic approach and regulatory approval process. Additionally, the approval of a drug in one tauopathy indication is likely to prompt its off-label use in other indications, driving sales further.

In particular, the report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global tauopathy therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global tauopathy therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Scope
- Overview of tauopathies including, etiology, pathophysiology, symptoms, diagnosis, and clinical trial challenges.
- Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the tauopathy therapeutics market.
- Pipeline analysis: focus on four late-stage pipeline tauopathy drugs, discussing emerging trends as well as an overview of earlier phase and preclinical drugs.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global tauopathy therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global tauopathy therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.